Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

2016 Advisory Board and Public Meetings

This page contains a listing of this year's Advisory Board and public meetings. When available, locations, times, telephone conference access information, agendas, and transcripts from the meetings are provided.

Information on worker outreach meetings can be found on individual site pages. A list of the individual site pages can be found on the List of Work Sites page.

2016 Meetings

JAN

FEB

MAR

APR

  • April 28 Teleconference Meeting of the Advisory Board's Subcommittee on Dose Reconstruction Reviews

    Time/Location:

    10:30 a.m. (Eastern Time)
    Meeting Type: Teleconference; Public, No Comment Period

    Teleconference: +1-866-659-0537
    Participant Code: 9933701

    Available Meeting Items:

    Select Another Month

MAY

  • May 16 Teleconference Meeting of the Advisory Board's Subcommittee on Procedures Review

    Time/Location:

    11:00 a.m. (Eastern Time)
    Meeting Type: Teleconference; Public, No Comment Period

    Teleconference: +1-866-659-0537
    Participant Code: 9933701

    Available Meeting Items:

    • Matters for Discussion: Discussion of procedures in the following ORAU and DCAS technical documents: OCAS Technical Information Bulletin (TIB) 0014 ("Rocky Flats Internal Dosimetry Coworker Extension"), ORAU OTIB 0013 ("Individual Dose Adjustment Procedures for Y–12 Dose Reconstructions"), ORAU OTIB 0029 ("Internal Dose Reconstructions for Y–12"), ORAU OTIB 0039 ("Internal Dose Reconstructions for Hanford"), ORAU OTIB 0050 ("The Use of Rocky Flats Neutron Dose Reconstruction Project Data in Dose Reconstructions"), ORAU OTIB 0060 ("Internal Dose Reconstructions"), Program Evaluation Report (PER) 003 ("The Effects of Adding Ingestion Intakes to Bethlehem Steel Cases"), PER 004 ("Application of Photofluorography at the Pinellas Plant"), PER 005 ("Misinterpreted Application of External Dose Factor for Hanford Dose Reconstructions"), PER 029 ("Hanford TBD Revision"), PER 042 ("Linde Ceramic Plant TBD Revision"), PER 045 ("Aliquippa Forge TBD Revision"), ORAU PROC 0042 ("Incomplete Monitoring at Y–12"), ORAU RPRT 0044 ("Analysis of Bioassay Data with Significant Fraction of Less-Than Results"); and a continuation of the comment-resolution process for other dose reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate.
    Select Another Month

JUN

No meetings have been scheduled for this month.

JUL

No meetings have been scheduled for this month.

AUG

No meetings have been scheduled for this month.

SEP

No meetings have been scheduled for this month.

OCT

No meetings have been scheduled for this month.

NOV

No meetings have been scheduled for this month.

DEC

No meetings have been scheduled for this month.

Pre-Decisional Document Policy

Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These pre-decisional documents, such as white papers, matrices, working drafts, etc., are distributed among Work Group members as research and background tools to facilitate discussion and deliberation. Although discussion during a public meeting may cover pre-decisional documents, these documents often are not further revised or finalized, and thus do not reflect the final determination or evaluation of the Advisory Board and its Work Groups. Additionally, some pre-decisional documents not otherwise posted on the website may contain sensitive information, which would require an interested party to obtain such documents by filing a Freedom of Information Act (FOIA) request the CDC/ATSDR FOIA office at foiarequests@cdc.gov.

 
Contact DCAS:
Contact Us:
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO